» Articles » PMID: 16213226

Cdk4 Promotes Adipogenesis Through PPARgamma Activation

Overview
Journal Cell Metab
Publisher Cell Press
Date 2005 Oct 11
PMID 16213226
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Cell cycle regulators such as E2F1 and retinoblastoma (RB) play crucial roles in the control of adipogenesis, mostly by controlling the transition between preadipocyte proliferation and adipocyte differentiation. The serine-threonine kinase cyclin-dependent kinase 4 (cdk4) works in a complex with D-type cyclins to phosphorylate RB, mediating the entry of cells into the cell cycle in response to external stimuli. Because cdk4 is an upstream regulator of the E2F-RB pathway, we tested whether cdk4 was a target for new factors that regulate adipogenesis. Here we find that cdk4 inhibition impairs adipocyte differentiation and function. Disruption of cdk4 or activating mutations in cdk4 in primary mouse embryonic fibroblasts results in reduced and increased adipogenic potential, respectively, of these cells. We show that the effects of cdk4 are not limited to the control of differentiation; cdk4 also participates in adipocyte function through activation of PPARgamma.

Citing Articles

Cyclin-dependent protein kinases and cell cycle regulation in biology and disease.

Pellarin I, DallAcqua A, Favero A, Segatto I, Rossi V, Crestan N Signal Transduct Target Ther. 2025; 10(1):11.

PMID: 39800748 PMC: 11734941. DOI: 10.1038/s41392-024-02080-z.


A non-canonical role of somatic Cyclin D/CYD-1 in oogenesis and in maintenance of reproductive fidelity, dependent on the FOXO/DAF-16 activation state.

Rautela U, Sarkar G, Chaudhary A, Chatterjee D, Rosh M, Arimbasseri A PLoS Genet. 2024; 20(11):e1011453.

PMID: 39546504 PMC: 11602045. DOI: 10.1371/journal.pgen.1011453.


Diet-induced Obesity: Pathophysiology, Consequences and Target Specific Therapeutic Strategies.

Banerjee M, Pandey V Curr Protein Pept Sci. 2024; 26(2):113-124.

PMID: 39225225 DOI: 10.2174/0113892037329528240827180820.


Evaluation of the relationship between toxicity of cyclin-dependent kinase 4/6 inhibitors and body surface area.

Disli S, Fidan E Rev Assoc Med Bras (1992). 2023; 69(12):e20230680.

PMID: 37971123 PMC: 10645177. DOI: 10.1590/1806-9282.20230680.


New role for the anandamide metabolite prostaglandin F ethanolamide: Rolling preadipocyte proliferation.

Boubertakh B, Courtemanche O, Marsolais D, Di Marzo V, Silvestri C J Lipid Res. 2023; 64(11):100444.

PMID: 37730163 PMC: 10622703. DOI: 10.1016/j.jlr.2023.100444.